Combination therapy for prostate cancer packs a powerful one-two punch
Boston , MA —Research suggests that adding hormonal therapy to standard treatments for prostate cancer can offer real advantages to men with advanced or high-grade disease that has not spread from the gland, according to the January issue of Harvard Men's Health Watch .
Scientists have made great progress in understanding prostate cancer. They've identified the genes that make some men particularly vulnerable to this disease and are starting to pinpoint the lifestyle factors linked to risk. Even the standard treatments have greatly improved. Surgical removal of the gland has become safer, and new techniques can help preserve potency. Innovative forms of radiation therapy allow oncologists to deliver more powerful treatment with fewer side effects. And new forms of hormonal drug therapy can dramatically lower levels of testosterone, which fuels the growth of prostate cells.